Title: Placenta-derived mesenchymal stem cells for allogenic cardiac cell therapy
Abstract: Objective: Mesenchymal stem cells (MSC) may be useful for cardiac cell therapy. While preparation of autologous MSC products is time consuming, allogenic immunotolerant MSC products would be available for off-the-shelf application. We sought to investigate the cardiac regeneration potential of a novel, placenta derived human MSC product (pMSC) in a mouse model of myocardial infarction.
Publication Year: 2012
Publication Date: 2012-01-18
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot